Session

Overview: The ESTRO Mobility/Grant reports symposium will give an overview of the awarded ESTRO Mobility Grants in 2019. Due to the pandemic this will be the last mobility reports until 2022. First, Dr. Helen Saxby will describe the implementation steps of MR-guided radiotherapy to treat oligometastases. Followed by Dr. Ivan Zhovannik, who will report on the distributed radiomics across three European radiation oncology centres. In her talk about SBRT for pancreatic tumours, Dr. Melpomeni Kountouri will give an overview of the role and current evidence of SBRT, as well as motion management strategies. Dr. Alessandro Cicchetti will focus on the biological features of skin effects after breast radiotherapy, with the goal of improving the reliability of predictive models of skin toxicity that include dosimetric and clinical factors. Furthermore, Dr. Jayson Paragas will share his experience of transitioning from 2D to IMRT in head and neck cancer.